Monday, April 19, 2021

바이든 대통령의 백신접종목표 "미국시민은 누구나 백신접종"달성, 아 부럽다. 우리는?

 바이든 대통령의 백신접종목표 "미국시민은 누구나 백신접종"달성, 아 부럽다.  접종을 원하는 미국시민들은 시간에 구애받지 않고 마음 편하게 접종을 즐길수(?)있다는 뜻이다.

아래의 상황들을 알아두면 많은 참고가 될것이다.

성인 미국시민들은 누구나 백신접종을 할수있는데, 이는 바이든 대통령의 시도했던 목표에 도달했다는 뜻으로, 미국시민들의 절반이상이 적어도 한번 접종을 끝낸셈이다.

지금부터는 모든 시민들은 접종을 다 하도록 독촉하는 일이다.

인도는 확진자 확산으로 약품과 산소에다, 인도 전체를 Lockdown까지 시켜야될 위기에 처해있다.

오스트랄리아와 뉴질랜드 국민들은 자유여행이 시작되고있는데, 가족들의 상봉이 이루어지고있다.

변종 바이러스의 확산을 막기위해 홍콩은 3개 나라로 부터 비행을 금하고 있다. 

불란서는 백신접종 예약이 매우 어렵다.  

뉴욕주는 1백50억달러를 들여 콘벤션센터에서 백신접종을 하고 있다. 원하는 사람은 누구나 OK.


Washington, D.C., 과 Puerto Rico를 포함하여 모든 미국시민들은, Covid-19백신 접종이 가능하며, 이렇게 되면 원래 바이든 대통령이 2주전에 세웠던 목표를 달성하게 되는것이다.

미국은 현재 하루에 약 3백2십만명에게 접종하고 있으며, 이는 한달전까지만해도 겨우 2백5십만명에게 접종가능 했었던것에 비하면 엄청난 속도로 접종되고 있다는 뜻이다.  지난 일요일 까지 1억3천 1백만명의 성인이 접종을 마쳤다는 뜻이며, 이는 미국전체 인구의 약 절반이 최소한 1차 접종했다는 뜻이며, 84백만명 이상이 2차접종까지 마쳤다는 뜻이다 라고 질병센터(Centers for Disease Control and Prevention )가 발표한것이다.

현재의 상태로 접종이 계속되면, 미국은 전체 인구의 70%이상이 6월중순까지 백신접종 완료된다. 

 Pfizer는 이번달에 발표하기를( announced this month ), 12세에서 15세 사이의 어린아이들에게 접종할수 있도록 비상조치를 당국이 승인 해줄것을 요청했었다.   Moderna는 십대청소년들에게 시험적으로 접종했던 결과를 곧 발표할것으로 보인다.  십대청소년들에게 접종이 공식적으로 허용되면 가을학기가 시작되기전에 접종이 시작될것으로 보인다.

 Dr. Fauci씨는 일요일에 설명하기를(said on Sunday ) 모든 연령의 청소년들이 2022년 1분기까지는 접종이 가능할것으로 예측된다고 했다.

미국에서는 백신접종이 피치를 올리고 있지만, 많은 나라들은 백신부족으로 고전을 면치 못하고있다.  Covid-19 vaccinations접종의 83%는 잘사는 나라들에서 접종된것이고, 0.2%만이 저개발 국가에서 접종된것이라고  New York Times vaccine tracker.가 발표하고 있다.

지금 상황으로 봤을때 우리 한국은 후자쪽에 속하는것 같아, 속상하며, 이렇게 상황을 악화시킨 원인은 노란자켓입고 폼만 잡았던, 문재인과, 정세균의 오만한 방역대책에서 일어난 재앙이라고 본다.


The last states expanded eligibility on Monday,. The administration is now turning to persuading more Americans to get vaccinated.

Adults in all U.S. states are now eligible for vaccination, hitting Biden’s target. Half have had at least one dose.

All adults in every U.S. state, Washington, D.C., and Puerto Rico are now eligible for a Covid-19 vaccine, meeting the April 19 deadline that President Biden set two weeks ago.

The United States is administering an average of 3.2 million doses a day, up from roughly 2.5 million a month before. More than 131 million people, or half of all American adults, had received at least one shot as of Sunday, according to the Centers for Disease Control and Prevention, and about 84.3 million people have been fully vaccinated.

Hawaii, Massachusetts, New Jersey, Oregon, Rhode Island and Vermont were the last states to expand eligibility, opening vaccinations to all adults on Monday.

“It’s truly historic that we have already reached this milestone,” said Dr. Nandita Mani, the associate medical director of infection prevention and control at the University of Washington Medical Center.

After a slow start, the pace of vaccinations has risen considerably in recent months. Mr. Biden, who initially said he wanted states to make all adults eligible for a vaccine by May 1, moved the deadline up as vaccinations accelerated. Mr. Biden has also set a goal of administering 200 million doses by his 100th day in office, which the nation is on pace to meet.

The expansion of eligibility comes as medical officials investigate whether Johnson & Johnson’s one-shot Covid-19 vaccine is linked to a rare blood-clotting disorder. All 50 states suspended administration of the vaccine last week, after federal health officials recommended a pause.

Dr. Anthony S. Fauci, the nation’s leading infectious disease expert, said on Sunday that federal regulators should come to a decision on Friday about whether to resume Johnson & Johnson vaccinations. Although he said he did not want to get ahead of the C.D.C. and the Food and Drug Administration, he said he expected experts to recommend “some sort of either warning or restriction” on the use of the vaccine.

Even if there is a link between the vaccine and the clotting disorder, the risk is exceedingly low, experts say.

Still, Dr. Mani said the pause was likely to harden the hesitancy of some Americans to get vaccinated.

At the same time, with the virus resurgent, public health experts are warning Americans not to let their guards down. The United States is averaging more than 67,000 new cases a day over the past seven days, up from over 54,000 a month ago, according to a New York Times database.

“Seventy thousand cases a day is not acceptable. We have to get that down,” said Barry Bloom, a research professor and former dean of the Harvard T.H. Chan School of Public Health. He said more vaccinations would help, but people must remain vigilant about wearing masks and social distancing.

At its current pace, the United States will vaccinate 70 percent of its population by mid-June. But vaccine hesitancy could slow progress toward herd immunity, which will also depend on vaccinating children.

Pfizer announced this month that it had applied for an emergency use authorization to make children ages 12 to 15 eligible for its vaccine. Moderna is expected to release results from its trial in young teenagers soon, and vaccinations in this age group could begin before school starts in the fall.

Trials in younger children are underway. Dr. Fauci also said on Sunday that he expected children of all ages to be eligible for vaccination in the first quarter of 2022.

Although vaccinations have picked up in the United States, many countries still face dire vaccine shortages. About 83 percent of Covid-19 vaccinations have been administered in high- and upper-middle-income countries, while only 0.2 percent of doses have been administered in low-income countries, according to a New York Times vaccine tracker.

Dr. Funmi Olopade, the director of the Center for Global Health at the University of Chicago, said it was crucial for the United States to step up its role in the global vaccination campaign as supply increases. The virus, left to spread around the world, could continue to mutate and threaten the nation’s economic recovery, she said.

It is in everybody’s “self-interest to provide whatever we can in the way of excess vaccines to low- and middle-income countries,” Dr. Bloom said.

Emily Anthes and 

https://www.nytimes.com/live/2021/04/19/world/covid-vaccine-coronavirus-cases/

No comments: